Before you use GLP-1 Companion feature or participate in this optional GLP-1 research check-in (together, the “Feature”), please read this Participant Consent Form carefully.
This form explains what data we may collect through this Feature, ask whether you use GLP-1 medication and when you started, how Simple may combine your answer with existing Simple data such as weight logs, BMI, app engagement, check-in activity, and related account data, how we may use that data for research purposes, how long we may keep it, and your rights, including how to withdraw your consent and request deletion of your data. Participation is voluntary. You can continue using the Simple app without using the Feature or participating in this research. The Feature is temporary, not a paid feature, and is made available only for this optional research program. It may no longer be available after you complete, skip, decline, or exit the research check-in, or after the research program ends. This does not affect your ability to continue using Simple or other features that are otherwise available to you.
Use of the Simple app is also governed by Simple’s Privacy Policy and Terms of Use. This Participant Consent Form is supplementary to those documents and covers only the use of your GLP-1 related data and related Simple data for research, analytics and aggregated reporting purposes. The processing of your data necessary for delivering Feature’s core functionality is governed by those primary documents and does not require this additional consent.
The Feature is a temporary, research-only experience in the Simple app. It may appear as a GLP-1-related button, card, prompt, screen, or check-in. Its purpose is to invite eligible users to answer an optional GLP-1 research check-in and, if they consent, allow Simple to use their answers and related Simple data for the research purposes described in this form.
The Feature is not intended to be a permanent product feature and does not create a right or expectation of continued access. It may be disabled, hidden, or no longer available after you complete, skip, decline, or exit the research check-in, or after the research program ends.
The purpose of this research is descriptive and observational. It is not a clinical trial, does not test the effectiveness or safety of any medication. We will not use the research results to provide medical advice to you, determine whether GLP-1 medication is appropriate for you, or make dosing, treatment, diagnosis, or safety recommendations.
This research also helps Simple evaluate and improve its services, user experiences, weight-management support, check-ins, and GLP-1-related product experiences.
The GLP-1 Companion feature allows users to track GLP-1 medication intake, view intake schedules, log and delete intake records, display a concentration graph, and receive push-notification dose reminders.
We wish to use the data collected through this Feature for internal research purposes, including to better understand observed weight-change outcomes, medication adherence patterns, pharmacokinetic trends, feature engagement, and health outcomes associated with use of Simple among consenting Simple users who self-report GLP-1 medication use.
As part of this, and subject to your consent, we may collect and process:
We may combine your answer with data already associated with your Simple account, including weight logs, BMI, onboarding answers, app engagement, check-in activity, and other relevant Simple usage data. GLP-1 medication status and therapy start timing are self-reported. Simple does not verify your medication use with a healthcare provider, pharmacy, insurer, or medical record.
Simple.Life Apps Inc.
8 The Green, Ste A, Dover, County of Kent, 19901, Delaware, USA.
Email:
support@simple.life
If you have questions about how your personal data is handled, you can contact our Data Protection Officer at: dpo@simple.life.
If you consent, we will collect and process the categories of data that you provide us with through the Feature. This may include:
This research is intended only for adults. The Feature is not shown to users we identify as under 18 years of age, and we do not knowingly collect GLP-1 research check-in data from minors.
We process this data for the purpose of conducting internal research, which includes:
The legal basis for collecting and processing your personal data is our legitimate interest in conducting the research, improvement of our services, and provision of a more reliable service to you (Article 6(1)(f) GDPR). The legal basis for collecting and processing your health and medication data for research and analytics purposes is your explicit consent (Article 9(2)(a) GDPR).
Where applicable U.S. state privacy laws require consent for the collection, processing or sharing of consumer health data, health data or sensitive personal information or sensitive personal data for purposes beyond service delivery (including under the California Consumer Privacy Act as amended, the Washington My Health My Data Act, the Connecticut Data Privacy Act, and analogous state laws), your explicit consent provided under this form satisfies those requirements.
You may withdraw your consent at any time as described in Section 10 below.
Consenting to research use of your GLP-1 medication data is entirely voluntary. You may continue using Simple without participating in this research. You may use the core functionality of the GLP-1 Companion feature (logging intake, viewing your schedule, receiving reminders, viewing the pharmacokinetic graph) without consenting to research use.
Declining or withdrawing consent will not affect your ability to use Simple. It also will not affect your access to any product features that are otherwise available to you.
If you do not consent, your medication data will be processed only as necessary to deliver the Feature’s services to you, as described in Simple’s Privacy Policy and Terms of Use.
You may also withdraw your consent to research use at any time by contacting us at dpo@simple.life.
Your personal data may be accessed only by authorized Simple personnel who need access for product operations, research, analytics, compliance, or support purposes.
Where possible, research outputs will be limited to aggregated and anonymized data. External collaborators, if any, will only receive anonymized or aggregated outputs unless an additional lawful basis and appropriate safeguards are in place.
We will not sell your personal data or share it with third parties for unrelated marketing purposes.
Your data may be processed by Simple and its service providers in the jurisdictions where they operate, in accordance with applicable data protection laws and contractual safeguards.
Where personal data is transferred internationally, we will use appropriate safeguards, such as Standard Contractual Clauses approved by the European Commission, an adequacy decision, or other lawful transfer mechanisms recognized under applicable law.
We will keep your personal data collected through this Feature for as long as your account exists in order to provide you with the proper functionality. When you withdraw your consent to the use of your personal data collected through this Feature for research purposes, it will not be deleted (since it is still required for the proper Feature functionality), but we will add you to a suppression list to make sure we do not use your personal data for the mentioned research purposes.
After expiry of the applicable retention period, personal data will be securely deleted or irreversibly de-identified.
You may withdraw your consent at any time, without giving a reason, by:
If you withdraw consent, we will stop future processing of your GLP-1 medication data for research purposes from that point onward. Withdrawal will not affect the lawfulness of processing carried out before withdrawal.
If data has already been irreversibly de-identified or included in aggregated analyses that no longer identify you, we will not be able to remove it from those analytics outputs.
To exercise any of these rights, please contact dpo@simple.life.
This Feature is for research and analytics purposes only.
Simple is not a medical device, does not provide medical advice, does not prescribe medication, does not determine whether GLP-1 medication is appropriate for you, and does not provide dosing, treatment, diagnosis, or safety recommendations.
Always follow instructions from your licensed healthcare provider. If you have questions about your medication, dosage, symptoms, side effects, or treatment plan, contact your healthcare provider.
Please confirm the following: